Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 198

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Refractory Hypertension: Definition, Prevalence, and Patient Characteristics

Open access
Acelajado, Maria Czarina, Pisoni, Roberto, Dudenbostel, Tanja, Dell’Italia, Louis J., Cartmill, Falynn, Zhang, Bin, Cofield, Stacey S., Oparil, Suzanne, Calhoun, David A. · 2012 · The Journal of Clinical Hypertension

Abstract

J Clin Hypertens (Greenwich). Among patients with resistant hypertension (RHTN), there are those whose blood pressure (BP) remains uncontrolled in spite of maximal medical therapy. This retrospective analysis aims to characterize these patients with refractory hypertension. Refractory hypertension was defined as BP that remained uncontrolled after ≥3 visits to a hypertension clinic within a minimum 6‐month follow‐up period. Of the 304 patients referred for RHTN, 29 (9.5%) remained refractory to treatment. Patients with refractory hypertension and those with controlled RHTN had similar aldosterone levels and plasma renin activity (PRA). Patients with refractory hypertension had higher baseline BP (175±23/97±15 mm Hg vs 158±25/89±15 mm Hg; P=.001/.005) and heart rate, and higher rates of prior stroke and congestive heart failure. During follow‐up, the BP of patients with refractory hypertension remained uncontrolled (168.4±14.8/93.8±17.7 mm Hg) in spite of use of an average of 6 antihypertensive medications, while those of patients with controlled RHTN decreased to 129.3±11.2/77.6±10.8 mm Hg. Spironolactone reduced the BP by 12.9±17.8/6.6±13.7 mm Hg in patients with refractory hypertension and by 24.1±16.7/9.2±12.0 mm Hg in patients with controlled RHTN. In patients with RHTN, approximately 10% remain refractory to treatment. Similar aldosterone and PRA levels and a diminished response to spironolactone suggest that aldosterone excess does not explain the treatment failure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1751-7176.2011.00556.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 198

Metadata

Authors
Acelajado, M. C., Pisoni, R., Dudenbostel, T., Dell’Italia, L. J., Cartmill, F., Zhang, B., Cofield, S. S., Oparil, S., & Calhoun, D. A.
Venue
The Journal of Clinical Hypertension
Publisher
Wiley
Published
2011-11-15
Volume
14
Issue
1
Pages
7-12
ISSN
  • 1524-6175 (ISSN-L)
  • 1751-7176
OpenAlex
W1771940925
Cited by
198
References
4
FWCI
11.69
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Refractory Hypertension: Definition, Prevalence, and Patient Characteristics. https://app.cochat.ai/papers/10.1111/j.1751-7176.2011.00556.x
The paper
Acelajado, M. C., Pisoni, R., Dudenbostel, T., Dell’Italia, L. J., Cartmill, F., Zhang, B., Cofield, S. S., Oparil, S., & Calhoun, D. A. (2012). Refractory Hypertension: Definition, Prevalence, and Patient Characteristics. The Journal of Clinical Hypertension. https://doi.org/10.1111/j.1751-7176.2011.00556.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.